1.345
Precedente Chiudi:
$1.435
Aprire:
$1.41
Volume 24 ore:
487.53K
Relative Volume:
1.48
Capitalizzazione di mercato:
$15.84M
Reddito:
$28.74M
Utile/perdita netta:
$-31.60M
Rapporto P/E:
-0.2647
EPS:
-5.0805
Flusso di cassa netto:
$-19.30M
1 W Prestazione:
-6.92%
1M Prestazione:
+10.25%
6M Prestazione:
+19.03%
1 anno Prestazione:
-31.03%
Bionano Genomics Inc Stock (BNGO) Company Profile
Nome
Bionano Genomics Inc
Settore
Industria
Telefono
(858) 888-7600
Indirizzo
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BNGO
Bionano Genomics Inc
|
1.345 | 15.84M | 28.74M | -31.60M | -19.30M | -5.0805 |
|
ISRG
Intuitive Surgical Inc
|
427.64 | 151.08B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
188.89 | 51.45B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
234.60 | 32.99B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.76 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
64.35 | 31.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-12 | Ripresa | BTIG Research | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2021-06-16 | Iniziato | BTIG Research | Buy |
| 2020-09-24 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-04-08 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Bionano Genomics Inc Borsa (BNGO) Ultime notizie
Viking Therapeutics plans $400M stock and conve... - Pluang
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance UK
Why Is Bionano Genomics (NASDAQ:BNGO) Standing Out as Traders Parse Sector Signals and Macro Pressure? - Kalkine Media
Why Has Bionano Genomics (BNGO) Returned to the Spotlight? - Kalkine Media
Local Coverage Determinations Roundup: ChromaCode, Biofidelity, Biocartis, Bionano Genomics - GenomeWeb
MolDX proposes Medicare coverage for Bionano genome mapping test - Investing.com
MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Canada
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - The Manila Times
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - marketscreener.com
MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Nigeria
Bionano Genomics (NasdaqCM:BNGO) Stock Forecast & Analyst Predictions - Simply Wall Street
Bionano Genomics (BNGO) interim CEO adds 4,000 shares in IRA - Stock Titan
Bionano Laboratories Announces New York State Department of - GlobeNewswire
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo
Bionano Genomics (NASDAQ:BNGO) Shares Turns Active on Today’s Market Trigger - Kalkine Media
Bionano Genomics Inc. Warrant (BNGOW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Peer Comparison – Compare with Others - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Bionano Genomics Inc. (BNGO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - Value Research
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Barchart.com
Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan
Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest TradingLong-Term Guidance - vinanet.vn
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com
Bionano Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Alex Reid Hastie Net Worth (2026) - GuruFocus
Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan
Gossamer Bio: Q2 Earnings Snapshot - AOL.com
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria
Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha
Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Canada
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade
Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade
BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative
How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media
Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Bionano Genomics Inc Azioni (BNGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bionano Genomics Inc Azioni (BNGO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Luderer Albert | Interim Chief Executive |
Aug 21 '26 |
Buy |
1.22 |
4,000 |
4,860 |
4,000 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):